A weight-loss drug banned in the U.S. over fears it can heighten the risk of suicide has been given the go-ahead in Britain.
Acomplia will be available to overweight or obese patients who cannot take, or who have had no success with, the two other weight-loss drugs available on the Health Service.
But a series of scientific studies have raised concerns that it can induce suicidal thoughts in those already suffering from depression.
The drug, taken orally as a pill once a day, has not been authorised in the U.S. because of safety fears, although it is available in France and Germany.
|
©Daily Mail
|
Obese patients in Britain will be offered Acomplia despite its known unsafe side-effects
|